Keywords: benefix, up, against, fda, panel, genetics, institute

BeneFix Up Against FDA Panel

Article | 02 December 1996

Print This

Genetics Institute's New Drug Application for its recombinant Factor IX product BeneFix is scheduled for review by the US Food ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in